{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:59:31Z","timestamp":1740149971518,"version":"3.37.3"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370889","81900562"],"award-info":[{"award-number":["81370889","81900562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012219","name":"Jiangsu Province Key Research and Development Program","doi-asserted-by":"publisher","award":["BE20161727"],"award-info":[{"award-number":["BE20161727"]}],"id":[{"id":"10.13039\/501100012219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2020,5,18]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hashimoto\u2019s thyroiditis (HT) is characterized by lymphocytic infiltration of\nthe thyroid parenchyma, which ultimately leads to tissue destruction and loss of function. Caveolin-1\n(Cav-1) is an essential structural constituent of lipid rafts in the plasma membrane of cells and is reported\nto be significantly reduced in thyrocytes from HT patients. However, the mechanism of Cav-1\ninvolvement in HT pathogenesis is still largely unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Cav-1 expression in thyroid tissues from HT patients and euthyroid nodular goiter tissues\nwas detected by immunohistochemistry staining. Cav-1 knockdown and overexpression were constructed\nby lentiviral transfection in the human thyroid follicular epithelial cell (TFC) line of Nthy-ori\n3-1. The mRNA expression levels of chemokines in TFCs were determined by quantitative real-time\nPCR (qPCR). Cav-1 and peroxisome proliferator-activated receptor gamma (PPAR\u03b3) levels were analysed\nby qPCR and Western blot analysis. The migration ability of peripheral blood mononuclear cells\n(PBMCs) was detected by the Transwell assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In this study, Cav-1 and PPAR\u03b3 expression was reduced in the thyroid tissues from HT patients.\nIn vitro experiments showed that the expressions of chemokine (C-C motif) ligand 5 (CCL5)\nand migration of PBMCs were markedly increased, while the level of PPAR\u03b3 was significantly decreased\nafter the lentivirus-mediated knockdown of Cav-1 in Nthy-ori 3-1 cells. Interestingly, pioglitazone,\na PPAR\u03b3 agonist, not only upregulated PPAR\u03b3 and Cav-1 proteins significantly, but also effectively\nreversed the Cav-1-knockdown-induced upregulation of CCL5 in Nthy-ori 3-1 cells and reduced\nthe infiltration of lymphocytes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The inhibition of Cav-1 upregulated the CCL5 expression and downregulated the PPAR\u03b3\nexpression in TFC while pioglitazone, a PPAR\u03b3 agonist, reversed the detrimental consequence. This\noutcome might be a potential target for the treatment of lymphocyte infiltration into the thyroid gland\nand HT development.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530319666191202115149","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T15:23:52Z","timestamp":1575300232000},"page":"609-618","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Caveolin-1 Regulates CCL5 and PPAR\u03b3 Expression in Nthy-ori 3-1 Cells: Possible Involvement of Caveolin-1 and CCL5 in the Pathogenesis of Hashimoto\u2019s Thyroiditis"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8698-4263","authenticated-orcid":true,"given":"Baocui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-1040","authenticated-orcid":true,"given":"Tingting","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-784X","authenticated-orcid":true,"given":"Liyang","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-658X","authenticated-orcid":true,"given":"Chaoming","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-0273","authenticated-orcid":true,"given":"Chengcheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6714-1794","authenticated-orcid":true,"given":"Xiao","family":"Mou","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-7926","authenticated-orcid":true,"given":"Xuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-9423","authenticated-orcid":true,"given":"Qingyan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9898-288X","authenticated-orcid":true,"given":"Xin","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-478X","authenticated-orcid":true,"given":"Jiameng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5585-2903","authenticated-orcid":true,"given":"Ping","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-9731","authenticated-orcid":true,"given":"Chao","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-6971","authenticated-orcid":true,"given":"Yichuan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-157X","authenticated-orcid":true,"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"Antonelli A.","year":"2015","unstructured":"Antonelli A.; Ferrari S.M.; Corrado A.; Di Domenicantonio A.; Fallahi P.; Autoimmune thyroid disorders. Autoimmun Rev 2015,14(2),174-180","journal-title":"Autoimmun Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"Golden S.H.","year":"2009","unstructured":"Golden S.H.; Robinson K.A.; Saldanha I.; Anton B.; Ladenson P.W.; Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009,94(6),1853-1878","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12020-015-0631-9","volume":"51","author":"Liu H.","year":"2016","unstructured":"Liu H.; Zheng T.; Mao Y.; Xu C.; Wu F.; Bu L.; Mou X.; Zhou Y.; Yuan G.; Wang S.; Zhou T.; Chen D.; Mao C.; \u03b3\u03b4 \u03a4 cells enhance B cells for antibody production in Hashimoto\u2019s thyroiditis, and retinoic acid induces apoptosis of the \u03b3\u03b4 \u03a4 cell. Endocrine 2016,51(1),113-122","journal-title":"Endocrine"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.0.1480001","volume":"148","author":"Weetman A.P.","year":"2003","unstructured":"Weetman A.P.; Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003,148(1),1-9","journal-title":"Eur J Endocrinol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-6413-4-10","volume":"4","author":"Bhatia A.","year":"2007","unstructured":"Bhatia A.; Rajwanshi A.; Dash R.J.; Mittal B.R.; Saxena A.K.; Lymphocytic thyroiditis--is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic and radionuclide parameters. Cytojournal 2007,4,10","journal-title":"Cytojournal"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0970-9371.188055","volume":"33","author":"Anila K.R.","year":"2016","unstructured":"Anila K.R.; Nayak N.; Jayasree K.; Cytomorphologic spectrum of lymphocytic thyroiditis and correlation between cytological grading and biochemical parameters. J Cytol 2016,33(3),145-149","journal-title":"J Cytol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.7314\/APJCP.2013.14.4.2295","volume":"14","author":"Wang X.X.","year":"2013","unstructured":"Wang X.X.; Wu Z.; Huang H.F.; Han C.; Zou W.; Liu J.; Caveolin-1, through its ability to negatively regulate TLR4, is a crucial determinant of MAPK activation in LPS-challenged mammary epithelial cells. Asian Pac J Cancer Prev 2013,14(4),2295-2299","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=8","first-page":"369","volume":"25","author":"Zhang X.","year":"2005","unstructured":"Zhang X.; Shen P.; Coleman M.; Zou W.; Loggie B.W.; Smith L.M.; Wang Z.; Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis. Anticancer Res 2005,25(1A),369-375","journal-title":"Anticancer Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1210\/jc.2007-0660","volume":"92","author":"Song Y.","year":"2007","unstructured":"Song Y.; Driessens N.; Costa M.; De Deken X.; Detours V.; Corvilain B.; Maenhaut C.; Miot F.; Van Sande J.; Many M.C.; Dumont J.E.; Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 2007,92(10),3764-3773","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/jc.2013-3469","volume":"99","author":"Marique L.","year":"2014","unstructured":"Marique L.; Van Regemorter V.; G\u00e9rard A.C.; Craps J.; Senou M.; Marbaix E.; Rahier J.; Daumerie C.; Mourad M.; Lengel\u00e9 B.; Colin I.M.; Many M.C.; The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1\/TH2) involved in thyroid autoimmune disorders. J Clin Endocrinol Metab 2014,99(5),1722-1732","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"E438","DOI":"10.1152\/ajpendo.90784.2008","volume":"297","author":"Senou M.","year":"2009","unstructured":"Senou M.; Costa M.J.; Massart C.; Thimmesch M.; Khalifa C.; Poncin S.; Boucquey M.; G\u00e9rard A.C.; Audinot J.N.; Dessy C.; Ruf J.; Feron O.; Devuyst O.; Guiot Y.; Dumont J.E.; Van Sande J.; Many M.C.; Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: in vivo study of caveolin-1 knockout mice. Am J Physiol Endocrinol Metab 2009,297(2),E438-E451","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1507\/endocrj.EJ18-0003","volume":"65","author":"Lu Q.","year":"2018","unstructured":"Lu Q.; Luo X.; Mao C.; Zheng T.; Liu B.; Dong X.; Zhou Y.; Xu C.; Mou X.; Wu F.; Bu L.; Yuan G.; Caveolin-1 regulates autophagy activity in thyroid follicular cells and is involved in Hashimoto\u2019s thyroiditis disease. Endocr J 2018,65(9),893-901","journal-title":"Endocr J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"Zlotnik A.","year":"2000","unstructured":"Zlotnik A.; Yoshie O.; Chemokines: a new classification system and their role in immunity. Immunity 2000,12(2),121-127","journal-title":"Immunity"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2018.01.016","volume":"116","author":"Nie X.","year":"2018","unstructured":"Nie X.; Tan J.; Dai Y.; Liu Y.; Zou J.; Sun J.; Ye S.; Shen C.; Fan L.; Chen J.; Bian J.S.; CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. J Mol Cell Cardiol 2018,116(116),41-56","journal-title":"J Mol Cell Cardiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1089\/thy.2007.0267","volume":"17","author":"Kimura H.","year":"2007","unstructured":"Kimura H.; Caturegli P.; Chemokine orchestration of autoimmune thyroiditis. Thyroid 2007,17(10),1005-1011","journal-title":"Thyroid"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","volume":"86","author":"Garc\u00eda-L\u00f3pez M.A.","year":"2001","unstructured":"Garc\u00eda-L\u00f3pez M.A.; Sancho D.; S\u00e1nchez-Madrid F.; Marazuela M.; Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 2001,86(10),5008-5016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","volume":"59","author":"Kemp E.H.","year":"2003","unstructured":"Kemp E.H.; Metcalfe R.A.; Smith K.A.; Woodroofe M.N.; Watson P.F.; Weetman A.P.; Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2003,59(2),207-213","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7150\/ijbs.10666","volume":"11","author":"Shen X.J.","year":"2015","unstructured":"Shen X.J.; Zhang H.; Tang G.S.; Wang X.D.; Zheng R.; Wang Y.; Zhu Y.; Xue X.C.; Bi J.W.; Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Int J Biol Sci 2015,11(4),370-379","journal-title":"Int J Biol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2016.07.008","volume":"75","author":"Xu C.","year":"2016","unstructured":"Xu C.; Wu F.; Mao C.; Wang X.; Zheng T.; Bu L.; Mou X.; Zhou Y.; Yuan G.; Wang S.; Xiao Y.; Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease. J Autoimmun 2016,75,50-57","journal-title":"J Autoimmun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fimmu.2018.00096","volume":"9","author":"Zheng T.","year":"2018","unstructured":"Zheng T.; Xu C.; Mao C.; Mou X.; Wu F.; Wang X.; Bu L.; Zhou Y.; Luo X.; Lu Q.; Liu H.; Yuan G.; Wang S.; Chen D.; Xiao Y.; Increased Interleukin-23 in Hashimoto\u2019s Thyroiditis Disease Induces Autophagy Suppression and Reactive Oxygen Species Accumulation. Front Immunol 2018,9,96","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/jc.2005-1475","volume":"91","author":"Chen M.P.","year":"2006","unstructured":"Chen M.P.; Chung F.M.; Chang D.M.; Tsai J.C.; Huang H.F.; Shin S.J.; Lee Y.J.; Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006,91(1),295-299","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1089\/thy.2015.0625","volume":"26","author":"Werion A.","year":"2016","unstructured":"Werion A.; Joris V.; Hepp M.; Papasokrati L.; Marique L.; de Ville de Goyet C.; Van Regemorter V.; Mourad M.; Lengel\u00e9 B.; Daumerie C.; Marbaix E.; Brichard S.; Many M.C.; Craps J.; Pioglitazone, a PPAR\u03b3 Agonist, Upregulates the Expression of Caveolin-1 and Catalase, Essential for Thyroid Cell Homeostasis: A Clue to the Pathogenesis of Hashimoto\u2019s Thyroiditis. Thyroid 2016,26(9),1320-1331","journal-title":"Thyroid"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21873\/cgp.20018","volume":"14","author":"Kim B.A.","year":"2017","unstructured":"Kim B.A.; Jee H.G.; Yi J.W.; Kim S.J.; Chai Y.J.; Choi J.Y.; Lee K.E.; Expression Profiling of a Human Thyroid Cell Line Stably Expressing the BRAFV600E Mutation. Cancer Genomics Proteomics 2017,14(1),53-67","journal-title":"Cancer Genomics Proteomics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/bjc.1989.387","volume":"60","author":"Lemoine N.R.","year":"1989","unstructured":"Lemoine N.R.; Mayall E.S.; Jones T.; Sheer D.; McDermid S.; Kendall-Taylor P.; Wynford-Thomas D.; Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer 1989,60(6),897-903","journal-title":"Br J Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc1254","volume":"4","author":"Michalik L.","year":"2004","unstructured":"Michalik L.; Desvergne B.; Wahli W.; Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat Rev Cancer 2004,4(1),61-70","journal-title":"Nat Rev Cancer"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1186\/ar3788","volume":"14","author":"Nebbaki S.S.","year":"2012","unstructured":"Nebbaki S.S.; El Mansouri F.E.; Afif H.; Kapoor M.; Benderdour M.; Duval N.; Pelletier J.P.; Martel-Pelletier J.; Fahmi H.; Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor \u03b3 expression in human osteoarthritic chondrocytes. Arthritis Res Ther 2012,14(2),R69","journal-title":"Arthritis Res Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1128\/MCB.01421-10","volume":"31","author":"Burgermeister E.","year":"2011","unstructured":"Burgermeister E.; Friedrich T.; Hitkova I.; Regel I.; Einw\u00e4chter H.; Zimmermann W.; R\u00f6cken C.; Perren A.; Wright M.B.; Schmid R.M.; Seger R.; Ebert M.P.; The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor \u03b3 through spatial relocalization at helix 7 of its ligand-binding domain. Mol Cell Biol 2011,31(16),3497-3510","journal-title":"Mol Cell Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1872214808666140623114315","volume":"8","author":"Fallahi P.","year":"2014","unstructured":"Fallahi P.; Ferrari S.M.; Corrado A.; Giuggioli D.; Ferri C.; Antonelli A.; Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity. Recent Pat Endocr Metab Immune Drug Discov 2014,8(2),95-101","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.imbio.2012.08.267","volume":"218","author":"Antonelli A.","year":"2013","unstructured":"Antonelli A.; Ferrari S.M.; Mancusi C.; Mazzi V.; Pupilli C.; Centanni M.; Ferri C.; Ferrannini E.; Fallahi P.; Interferon-\u03b1, -\u03b2 and -\u03b3 induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor \u03b3 agonists. Immunobiology 2013,218(5),690-695","journal-title":"Immunobiology"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/325183","volume":"2010","author":"Rogue A.","year":"2010","unstructured":"Rogue A.; Spire C.; Brun M.; Claude N.; Guillouzo A.; Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver. PPAR Res 2010,2010","journal-title":"PPAR Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.imbio.2012.05.016","volume":"218","author":"Rebuffat S.A.","year":"2013","unstructured":"Rebuffat S.A.; Kammoun-Krichen M.; Charfeddine I.; Ayadi H.; Bougacha-Elleuch N.; Peraldi-Roux S.; IL-1\u03b2 and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology 2013,218(3),285-291","journal-title":"Immunobiology"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/979167","volume":"2015","author":"Pyzik A.","year":"2015","unstructured":"Pyzik A.; Grywalska E.; Matyjaszek-Matuszek B.; Roli\u0144ski J.; Immune disorders in Hashimoto\u2019s thyroiditis: what do we know so far? J Immunol Res 2015,2015","journal-title":"J Immunol Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000078438","volume":"11","author":"Phenekos C.","year":"2004","unstructured":"Phenekos C.; Vryonidou A.; Gritzapis A.D.; Baxevanis C.N.; Goula M.; Papamichail M.; Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto\u2019s thyroiditis (Th1) and Graves\u2019 disease (Th2). Neuroimmunomodulation 2004,11(4),209-213","journal-title":"Neuroimmunomodulation"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0960-5428(97)00027-7","volume":"6","author":"Ajjan R.A.","year":"1996","unstructured":"Ajjan R.A.; Watson P.F.; Weetman A.P.; Cytokines and thyroid function. Adv Neuroimmunol 1996,6(4),359-386","journal-title":"Adv Neuroimmunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.275.5302.960","volume":"275","author":"Giordano C.","year":"1997","unstructured":"Giordano C.; Stassi G.; De Maria R.; Todaro M.; Richiusa P.; Papoff G.; Ruberti G.; Bagnasco M.; Testi R.; Galluzzo A.; Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto\u2019s thyroiditis. Science 1997,275(5302),960-963","journal-title":"Science"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/carcin\/bgt142","volume":"34","author":"Friedrich T.","year":"2013","unstructured":"Friedrich T.; Richter B.; Gaiser T.; Weiss C.; Janssen K.P.; Einw\u00e4chter H.; Schmid R.M.; Ebert M.P.; Burgermeister E.; Deficiency of caveolin-1 in Apc(min\/+) mice promotes colorectal tumorigenesis. Carcinogenesis 2013,34(9),2109-2118","journal-title":"Carcinogenesis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/cvr\/cvq075","volume":"86","author":"Chidlow J.H.","year":"2010","unstructured":"Chidlow J.H.; Sessa W.C.; Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 2010,86(2),219-225","journal-title":"Cardiovasc Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.4161\/cc.10.11.15674","volume":"10","author":"Martinez-Outschoorn U.E.","year":"2011","unstructured":"Martinez-Outschoorn U.E.; Whitaker-Menezes D.; Lin Z.; Flomenberg N.; Howell A.; Pestell R.G.; Lisanti M.P.; Sotgia F.; Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011,10(11),1784-1793","journal-title":"Cell Cycle"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"R384","DOI":"10.1016\/S0960-9822(06)00181-3","volume":"7","author":"Mackay C.R.","year":"1997","unstructured":"Mackay C.R.; Chemokines: what chemokine is that? Curr Biol 1997,7(6),R384-R386","journal-title":"Curr Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"Zlotnik A.","year":"2000","unstructured":"Zlotnik A.; Yoshie O.; Chemokines: a new classification system and their role in immunity. Immunity 2000,12(2),121-127","journal-title":"Immunity"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/s-0032-1308973","volume":"44","author":"Gu X.","year":"2012","unstructured":"Gu X.; Zheng L.; Chen X.; Ruan L.; Zhang H.; Ge S.; Zhu H.; Lin X.; Shen F.; Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy. Horm Metab Res 2012,44(6),482-487","journal-title":"Horm Metab Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","volume":"79","author":"Tontonoz P.","year":"1994","unstructured":"Tontonoz P.; Hu E.; Spiegelman B.M.; Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994,79(7),1147-1156","journal-title":"Cell"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","volume":"4","author":"Rosen E.D.","year":"1999","unstructured":"Rosen E.D.; Sarraf P.; Troy A.E.; Bradwin G.; Moore K.; Milstone D.S.; Spiegelman B.M.; Mortensen R.M.; PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999,4(4),611-617","journal-title":"Mol Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/47254","volume":"402","author":"Barroso I.","year":"1999","unstructured":"Barroso I.; Gurnell M.; Crowley V.E.; Agostini M.; Schwabe J.W.; Soos M.A.; Maslen G.L.; Williams T.D.; Lewis H.; Schafer A.J.; Chatterjee V.K.; O\u2019Rahilly S.; Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999,402(6764),880-883","journal-title":"Nature"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","volume":"123","author":"Lehrke M.","year":"2005","unstructured":"Lehrke M.; Lazar M.A.; The many faces of PPARgamma. Cell 2005,123(6),993-999","journal-title":"Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1194\/jlr.M400049-JLR200","volume":"45","author":"Llaverias G.","year":"2004","unstructured":"Llaverias G.; V\u00e1zquez-Carrera M.; S\u00e1nchez R.M.; No\u00e9 V.; Ciudad C.J.; Laguna J.C.; Alegret M.; Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J Lipid Res 2004,45(11),2015-2024","journal-title":"J Lipid Res"},{"key":"ref=47","first-page":"895","volume":"28","author":"Tencer L.","year":"2008","unstructured":"Tencer L.; Burgermeister E.; Ebert M.P.; Liscovitch M.; Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Res 2008,28(2A),895-906","journal-title":"Anticancer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/carcin\/bgn103","volume":"29","author":"Lei P.","year":"2008","unstructured":"Lei P.; Abdelrahim M.; Cho S.D.; Liu S.; Chintharlapalli S.; Safe S.; 1,1-Bis(3\u2032-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase. Carcinogenesis 2008,29(6),1139-1147","journal-title":"Carcinogenesis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1038\/sj.onc.1206625","volume":"22","author":"Burgermeister E.","year":"2003","unstructured":"Burgermeister E.; Tencer L.; Liscovitch M.; Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 2003,22(25),3888-3900","journal-title":"Oncogene"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T10:51:54Z","timestamp":1596019914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177089\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5,18]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666191202115149","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}